Leaflet MILDRONATE 500mg / 5ml solution for injection

Product code:
W71187001
Quantity:
10
Indicated for:
cardiac metabolic support
Route of administration:
injectable
Substance:
meldoniu (anti-ischemic metabolic agent)
ATC
C01EB22 — Cardiovascular system | Other cardiac preparations
Meldonium is a medication used to improve physical performance and treat cardiovascular conditions such as angina and heart failure. It works by optimizing cellular metabolism and increasing oxygen flow to tissues.

The drug is commonly used in Eastern Europe and Central Asia but is not approved for use in many other countries. Meldonium is available in capsule or injectable solution form, and the dosage is adjusted based on the condition being treated.

Although considered safe at therapeutic doses, meldonium may cause side effects such as headaches, dizziness, nausea, or allergic reactions. Its use has been controversial in sports, as it has been banned by the World Anti-Doping Agency (WADA) since 2016.

Patients taking meldonium should be monitored by a doctor, especially if they have other chronic conditions or are taking additional medications. Pregnant or breastfeeding women should avoid using this medication without a specialist's recommendation.

General data about MILDRONATE 500mg / 5ml

Substance:
meldoniu
Date of latest medicines list:
01-07-2025
Product code:
W71187001
Concentration:
500mg / 5ml
Pharmaceutical form:
solution for injection
Quantity:
10
Product type:
Generic medicine
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
AS GRINDEKS - LETONIA
Holder:
AS GRINDEKS - LETONIA
Number:
16085/2025/01
Shelf life:
2 years

Pharmaceutical forms available for meldoniu

Concentrations available for meldoniu

  • 500mg
  • 500mg/5ml